McKessonPrefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.
Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
McKesson (MCK) reported revenue of $96.30B in Q1 2026, with North American Pharmaceutical its largest revenue segment at 83%.
McKessonLargest US pharmaceutical distributor by revenue, with oncology and specialty provider platforms alongside core wholesale. Management attributes much of recent revenue growth to GLP-1 adoption plus branded pharmaceutical demand, though the products carry thin distribution margins.
McKesson (MCK) is a Medical - Distribution company. Largest US pharmaceutical distributor by revenue, with oncology and specialty provider platforms alongside core wholesale. Management attributes much of recent revenue growth to GLP-1 adoption plus branded pharmaceutical demand, though the products carry thin distribution margins. It was founded in 1833, is headquartered in Irving, TX and employs about 43,000 people.
As of 2025-Q4, McKesson's revenue breaks down across North American Pharmaceutical (83%), Oncology & Multispecialty (12%), Medical-Surgical Solutions (3%), Prescription Technology Solutions (1%). See the revenue-by-segment chart for the full mix.
Track McKesson's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated September 28, 2026.
Sterling groups McKesson in the GLP-1 industry, alongside Hims & Hers Health (HIMS), Cencora (COR), Cardinal Health (CAH) and CVS Health (CVS).
If you are researching McKesson, also look at Hims & Hers Health (HIMS), Cencora (COR) and Cardinal Health (CAH). You can compare all of them side by side or browse the full GLP-1 industry on Sterling.
Q2 2016-Q1 2026
Q2 2016-Q1 2026